Fosfomycin Tromethamine
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Aucta Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 1 | SUPPLYING |
| A-S Medication Solutions | repackager | 1 | SUPPLYING |
| Kesin Pharma Corporation | unknown | 1 | SUPPLYING |
| Ascend Laboratories, LLC | generic | 1 | SUPPLYING |
| Cipla USA Inc. | generic | 1 | SUPPLYING |
| Amneal Pharmaceuticals LLC | generic | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed Impurities/Degradation Specification: Out of specification for organic impurities — Recalling firm: Ascend Laboratories, LLC — Nationwide in the USA
Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability. — Recalling firm: Ascend Laboratories, LLC — The recall product was distributed nationwide.
